Silence Therapeutics (SLN) FCF Margin (2024 - 2026)
Silence Therapeutics (SLN) reported FCF Margin of 3697.39% for Q1 2026, up 497373.0% on a YoY basis from N/an in Q1 2025, and up 92.74% sequentially from 50929.41% in Q4 2025.
Silence Therapeutics (SLN) FCF Margin (2024 - 2026) Analysis & Trends
Silence Therapeutics (SLN) has 3 years of FCF Margin data on file, last reported at 3697.39% in Q1 2026.
- For the quarter ending Q1 2026, FCF Margin rose 497373.0% year-over-year to 3697.39%; the trailing twelve-month figure through Mar 2026 stood at 7824.2% (down 756822.0% YoY), and the FY2025 full-year result was 11154.74%, down 1099789.0% from the prior year.
- FCF Margin improved to 3697.39% in Q1 2026, from 50929.41% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 58.24% in Q1 2024 to a low of 50929.41% in Q4 2025.
- A 3-year average of 9158.87% and a median of 3697.39% in 2026 frame the typical range for FCF Margin.
- Across the five-year window, FCF Margin plunged 5081777 bps in 2025 and soared 497373 bps in 2026, its largest moves.
- Tracing SLN's FCF Margin over 3 years: stood at 111.64% in 2024, then slumped by 45520 bps to 50929.41% in 2025, then surged by 93 bps to 3697.39% in 2026.
- Business Quant data shows SLN's FCF Margin at 3697.39% in Q1 2026, 50929.41% in Q4 2025, and 6888.68% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.45% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Silence Therapeutics | 1.62 Bn | 1.49 Bn | 411,000.00 | -3,697.39% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,697.39% |
| Dec 31, 2025 | -50,929.41% |
| Sep 30, 2025 | -6,888.68% |
| Jun 30, 2025 | -9,720.09% |
| Mar 31, 2025 | -8,671.13% |
| Dec 31, 2024 | -111.64% |
| Sep 30, 2024 | -1,666.49% |
| Jun 30, 2024 | -686.75% |
| Mar 31, 2024 | -58.24% |